These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5437411)

  • 21. [Changes in the electrocardiogramm in relation to electrolyte and pH shifts during hemodialysis].
    Steinbach K; Egert H
    Wien Z Inn Med; 1970; 51(8):366-75. PubMed ID: 5512985
    [No Abstract]   [Full Text] [Related]  

  • 22. Unrecognized pseudohyperkalemia as a cause of elevated potassium in patients with renal disease.
    Ifudu O; Markell MS; Friedman EA
    Am J Nephrol; 1992; 12(1-2):102-4. PubMed ID: 1415352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
    Montoliu J; Lens XM; Revert L
    Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potassium dynamics are attenuated in hyperkalemia and a determinant of QT adaptation in exercising hemodialysis patients.
    Tran CT; Bundgaard H; Ladefoged SD; Haunsø S; Kjeldsen K
    J Appl Physiol (1985); 2013 Aug; 115(4):498-504. PubMed ID: 23722704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of plasma aldosterone during hemodialysis in patients with terminal renal failure.
    Vetter W; Záruba K; Armbruster H; Beckerhoff R; Nussberger J; Furrer J; Fontana A; Siegenthaler W
    Nephron; 1977; 18(2):114-23. PubMed ID: 857174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonselective Beta-adrenergic blockade augments fasting hyperkalemia in hemodialysis patients.
    Nowicki M; Miszczak-Kuban J
    Nephron; 2002 Jun; 91(2):222-7. PubMed ID: 12053057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colloid osmotic pressure fluctuations and the disequilibrium syndrome during hemodialysis.
    Cerra FB; Anthone R; Anthone S
    Nephron; 1974; 13(3):245-52. PubMed ID: 4422817
    [No Abstract]   [Full Text] [Related]  

  • 28. [Optimal composition of the dialyzing solution in chronic hemodialysis].
    Verkhovskiĭ BD; Paleev NR; Shcherbakova EO
    Urol Nefrol (Mosk); 1975; (1):29-35. PubMed ID: 1118969
    [No Abstract]   [Full Text] [Related]  

  • 29. Can a 12-lead ECG be used to assess for hyperkalemia?
    Thompson C; Tsiperfal A
    Prog Cardiovasc Nurs; 2003; 18(2):112, 114. PubMed ID: 12732805
    [No Abstract]   [Full Text] [Related]  

  • 30. Bradycardia without "classical" EKG changes in hyperkalemic hemodialysis patients.
    Mohanlal V; Haririan A; Weinman EJ
    Clin Nephrol; 2013 Dec; 80(6):464-8. PubMed ID: 22784561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanisms of hypertension in patients with terminal kidney failure on programmed hemodialysis].
    Krimkevich EI; Petrun' NM; Baran EIa; Kutsaĭ NN; Khomenko NV
    Ter Arkh; 1986; 58(8):81-4. PubMed ID: 3020729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients.
    Kim HJ
    Nephron; 1996; 72(3):476-82. PubMed ID: 8852501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrocardiographic R wave increases after hemodialysis: round III.
    Diskin CJ
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):648-50; author reply 650. PubMed ID: 18580031
    [No Abstract]   [Full Text] [Related]  

  • 34. [Plasma-renin in acute and chronic kidney insufficiency and hemodialysis].
    Schröder E; Herms W; Wetzels E; Dume T; Grabensee B
    Dtsch Med Wochenschr; 1969 Oct; 94(44):2262-7. PubMed ID: 5350092
    [No Abstract]   [Full Text] [Related]  

  • 35. Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis.
    Furuya R; Kumagai H; Sakao T; Maruyama Y; Hishida A
    Nephron; 2002; 92(3):576-81. PubMed ID: 12372940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolated jejunal loop dialysis in the management of chronic renal failure.
    Parisi R; Stephen RL
    Med J Aust; 1972 Jan; 1(3):100-6. PubMed ID: 5060471
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sodium and potassium concentrations in the erythrocytes of patients undergoing chronic hemodialysis. (I)--Effects of hemodialysis on the erythrocyte sodium and potassium concentrations (author's transl)].
    Imada A; Horiuchi A; Kawauchi Y; Kogi Y
    Rinsho Byori; 1982 Jan; 30(1):82-6. PubMed ID: 7087235
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of dialysis treatment on the oxygen affinity of hemoglobin in chronic kidney failure].
    Amor H; Humpeler E; Dittrich P
    Schweiz Med Wochenschr; 1974 Mar; 104(13):453-8. PubMed ID: 4824416
    [No Abstract]   [Full Text] [Related]  

  • 39. Temporal profile of serum potassium concentration in nondiabetic and diabetic outpatients on chronic dialysis.
    Tzamaloukas AH; Avasthi PS
    Am J Nephrol; 1987; 7(2):101-9. PubMed ID: 3605230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sodium and potassium content of erythrocytes at the terminal stage of chronic renal insufficiency and during treatment by chronic hemodialysis].
    Terekhov NT; Goligorskiĭ MS; Kremen' MG; Vasilenko VK
    Urol Nefrol (Mosk); 1974; (6):10-4. PubMed ID: 4141153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.